Author: Muro, Antonio; Belhassen-GarcÃa, Moncef; Muñoz Bellido, Juan LuÃs; Lorenzo Juanes, Helena; Vicente, Belén; Pendones, Josué; Adserias, José; Sánchez Hernández, Gonzalo; RodrÃguez Rosa, Miguel; Vicente Villardón, José Luis; Burguillo, Javier; López Andaluz, Javier; MartÃn Oterino, Jose Angel; GarcÃa Criado, Francisco Javier; Barbero, Fausto; Morales, Ana Isabel; Galindo Villardón, Purificación; González Sarmiento, Rogelio
Title: Seroprevalence of SARS-CoV-2 Antibodies and Factors Associated with Seropositivity at the University of Salamanca: The DIANCUSAL Study Cord-id: bjnwouxb Document date: 2021_7_21
ID: bjnwouxb
Snippet: Background: Systematic screening for antibodies against SARS-CoV-2 is a crucial tool for surveillance of the COVID-19 pandemic. The University of Salamanca (USAL) in Spain designed a project called “DIANCUSAL†(Diagnosis of New Coronavirus, COVID-19, in University of Salamanca) to measure antibodies against SARS-CoV-2 among its ~34,000 students and academic staff, as the influence of the university community in the spread of the SARS-CoV-2 pandemic in the city of Salamanca and neighboring to
Document: Background: Systematic screening for antibodies against SARS-CoV-2 is a crucial tool for surveillance of the COVID-19 pandemic. The University of Salamanca (USAL) in Spain designed a project called “DIANCUSAL†(Diagnosis of New Coronavirus, COVID-19, in University of Salamanca) to measure antibodies against SARS-CoV-2 among its ~34,000 students and academic staff, as the influence of the university community in the spread of the SARS-CoV-2 pandemic in the city of Salamanca and neighboring towns hosting USAL campuses could be substantial. Objective: The aim of this study was to estimate the prevalence of SARS-CoV-2 antibodies among USAL students, professors and staff and to evaluate the demographic, academic, clinical and lifestyle and behavioral factors related to seropositivity. Methodology: The DIANCUSAL study is an ongoing university population-based cross-sectional study, with the work described herein conducted from July–October 2020. All USAL students, professors and staff were invited to complete an anonymized questionnaire. Seroprevalence of anti-SARS-CoV-2 antibodies was detected and quantified by using chemiluminescent assays for IgG and IgM. Principal findings: A total of 8197 (24.71%) participants were included. The mean age was 31.4 (14.5 SD) years, and 66.0% of the participants were female. The seroprevalence was 8.25% overall and was highest for students from the education campus (12.5%) and professors from the biomedical campus (12.6%), with significant differences among faculties (p = 0.006). Based on the questionnaire, loss of smell and fever were the symptoms most strongly associated with seropositivity, and 22.6% of seropositive participants were asymptomatic. Social distancing was the most effective hygiene measure (p = 0.0007). There were significant differences in seroprevalence between participants with and without household exposure to SARS-CoV-2 (p = 0.0000), but not between students who lived in private homes and those who lived in dormitories. IgG antibodies decreased over time in the participants with confirmed self-reported COVID-19 diagnoses. Conclusions: The analysis revealed an overall 8.25% seroprevalence at the end of October 2020, with a higher seroprevalence in students than in staff. Thus, there is no need for tailored measures for the USAL community as the official average seroprevalence in the area was similar (7.8% at 22 June and 12.4 at 15 November of 2020). Instead, USAL members should comply with public health measures.
Search related documents:
Co phrase search for related documents- abo blood group and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- abo blood group and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- absolute value and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- absolute value and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- academic community and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- academic community and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- academic institution and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9
- academic institution and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8
- academic population and acute respiratory syndrome: 1, 2, 3, 4, 5
- academic population and acute respiratory syndrome coronavirus: 1, 2, 3
- academic staff and acute respiratory syndrome: 1
- academic staff and acute respiratory syndrome coronavirus: 1
- academic year and acute respiratory syndrome: 1, 2, 3, 4, 5
- academic year and acute respiratory syndrome coronavirus: 1, 2, 3, 4
- activity exposure and acute respiratory syndrome: 1, 2, 3
- activity exposure and acute respiratory syndrome coronavirus: 1, 2
- acute respiratory syndrome and administrative officer: 1
Co phrase search for related documents, hyperlinks ordered by date